Adult live donor liver transplantation: routine, commonplace, standard care for end stage liver disease (we hope)

by Eric M. Yoshida, Mazhar Haque, Charles H. Scudamore
Published 2010-01-01

Hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial

by Mazhar Haque, Eric M. Yoshida, MD, MHSc, FRCP(C), FACP, FACG
Published 2009-01-01

Hepatic lymphoma in a post renal transplant patient with chronic hepatitis B

by Mazhar Haque, Douglas L Webber, Paula Kebarle, R. Jean Shapiro, Eric M Yoshida
Published 2010-01-01

In a ‘Real-World’, Clinic-Based Community Setting, Sorafenib Dose of 400 mg/day is as Effective as Standard Dose of 800 mg/day in Patients with Advanced Hepatocellular Carcimona, w...

by Alexandra Shingina, Al Moutaz Hashim, Mazhar Haque, Michael Suen, Eric M Yoshida, Sharlene Gill, Fergal Donnellan, Alan A Weiss
Published 2013-01-01

Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia

by M Masudur Rahman, Mazhar Haque, Md Golam Kibria, Hasina Begum, Nigar Sultana, Mahfuza Akhter, A H M Rowshon, Faruqe Ahmed, Mahmud Hasan
Published 2020-11-01

Late acute celiac and hepatic artery thrombosis with portal vein thrombosis resulting in hepatic infarction 12 years post orthotopic liver transplantation

by Mazhar Haque, P. Andrew Schumacher, Alison Harris, Charles H. Scudamore, Urs P. Steinbrecher, Stephen W Chung, Andrzej K. Buczkowski, Siegfried R. Erb, Eric M. Yoshida
Published 2009-10-01